Contact
Please use this form to send email to PR contact of this press release:
SRPT INVESTIGATION ALERT: Robbins Geller Rudman & Dowd LLP Announces Ongoing Investigation into Sarepta Therapeutics, Inc. and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
TO: